Neurogenetics tests in Dubai & UAE

Compare available Neurogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

-1.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetics test prices

Showing 31–45 of 68 matching tests.

Neurogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4707 GBA Gene Lewy Body Dementia Susceptibility Genetic Test This genetic test evaluates the GBA gene for mutations associated with an increased susceptibility to developing Lewy Body Dementia.	Whole Blood (EDTA, 4 mL), Extracted DNA (≥2 µg at ≥50 ng/µL), or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GBA gene sequence", "Copy Number Variations (CNV) in GBA gene"] Parameters [{"name": "GBA Gene Coverage", "reference_range": "Full Gene Coverage: All 11 exons, intron-exon boundaries, deep intronic regulatory regions; CNV detection included"}, {"name": "Methodology", "reference_range": "NGS (Next-Generation Sequencing) with 300x average read depth"}, {"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["Mandatory Pre-Test Genetic Counseling session required"] Indications ["Family history of LBD, Parkinson's disease, or Gaucher disease", "Presence of prodromal symptoms (REM sleep behavior disorder, autonomic dysfunction, fluctuating cognition)"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: G31.83 Clinical summary This genetic test evaluates the GBA gene for mutations associated with an increased susceptibility to developing Lewy Body Dementia.
TEST-4067 GJB1 Gene CMTX1 Genetic Test This test evaluates the GJB1 gene for pathogenic variants associated with X-linked Charcot-Marie-Tooth disease type 1.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJB1 gene", "Coding regions and splice sites"] Parameters [] Preparation ["No fasting or special preparation required", "Pre-test genetic counselling session is compulsory"] Indications ["Individuals with a family history of Charcot-Marie-Tooth disease", "Symptomatic males and carrier females with a positive pedigree", "Unexplained progressive distal muscle weakness", "Foot deformities", "Sensory loss"] Measurement technique Confirm with laboratory Codes LOINC: 21636-7 ICD-10: G60.0 Clinical summary This test evaluates the GJB1 gene for pathogenic variants associated with X-linked Charcot-Marie-Tooth disease type 1.
TEST-4188 GRN-Associated Frontotemporal Dementia (FTD) Genetic Test This test evaluates the GRN gene for pathogenic variants associated with frontotemporal dementia.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GRN gene pathogenic variants", "Mutations in coding exons and splice sites"] Parameters [] Preparation [] Indications ["Suspected Frontotemporal Dementia", "Family history of FTD", "Differential diagnosis of dementia"] Measurement technique Confirm with laboratory Codes LOINC: 94635-8 ICD-10: G31.09 Clinical summary This test evaluates the GRN gene for pathogenic variants associated with frontotemporal dementia.
TEST-5346 HINT1 Gene Neuromyotonia and Axonal Neuropathy, Autosomal Recessive Genetic Test This test evaluates the HINT1 gene for pathogenic variants associated with autosomal recessive neuromyotonia and axonal neuropathy.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HINT1 gene sequence", "Pathogenic variants in HINT1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected HINT1-related neuromyotonia and axonal neuropathy", "Family history of HINT1-related disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.1, G60.0 Clinical summary This test evaluates the HINT1 gene for pathogenic variants associated with autosomal recessive neuromyotonia and axonal neuropathy.
TEST-5356 HSPB1 Gene Neuronopathy Distal Hereditary Motor Neuropathy Type 2B Genetic Test This genetic test identifies pathogenic variants in the HSPB1 gene, confirming a diagnosis of distal hereditary motor neuropathy type 2B.	Whole Blood, Extracted DNA, or FTA Card (Peripheral Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in HSPB1 gene", "Single nucleotide variants", "Small indels", "Copy number variations (CNV)"] Parameters [] Preparation [] Indications ["Suspected distal hereditary motor neuropathy type 2B", "Family history of HMN2B", "Neurological assessment suggestive of HMN2B"] Measurement technique Confirm with laboratory Codes LOINC: 82325-7 ICD-10: G60.8 Clinical summary This genetic test identifies pathogenic variants in the HSPB1 gene, confirming a diagnosis of distal hereditary motor neuropathy type 2B.
TEST-4516 HTT Gene Huntington Disease Genetic Test (NGS) This test evaluates the number of CAG trinucleotide repeats in the HTT gene to diagnose Huntington disease or assess genetic risk.	EDTA Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansions in the HTT gene", "Rare allele detection"] Parameters [] Preparation [] Indications ["Documented family history of Huntington disease", "Presence of suggestive motor, cognitive, or psychiatric symptoms", "Predictive testing for asymptomatic adults with family history"] Measurement technique Confirm with laboratory Codes LOINC: 21669-3 ICD-10: G10 Clinical summary This test evaluates the number of CAG trinucleotide repeats in the HTT gene to diagnose Huntington disease or assess genetic risk.
TEST-2588 HUWE1 Gene Mental Retardation, X-Linked Syndromic, Turner Type Test This genetic test identifies pathogenic variants in the HUWE1 gene associated with X-linked syndromic intellectual disability (Turner type). It utilizes next-generation sequencing...	Peripheral whole blood (EDTA)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HUWE1 gene", "Single-nucleotide variants"] Parameters [] Preparation ["Fasting is not required", "Keep the child well-hydrated", "Inform the phlebotomist about any medications"] Indications ["Suspected X-linked syndromic intellectual disability (Turner type)", "Pediatric patients with developmental delay and dysmorphism"] Measurement technique Confirm with laboratory Codes LOINC: 81311-0 ICD-10: F78.8 Clinical summary This genetic test identifies pathogenic variants in the HUWE1 gene associated with X-linked syndromic intellectual disability (Turner type). It utilizes next-generation sequencing to detect single-nucleotide variants.
TEST-4836 KAT6A Gene Intellectual Disability (Autosomal Dominant Type 32) NGS Test This diagnostic test evaluates the KAT6A gene for pathogenic variants associated with autosomal dominant intellectual disability type 32.	Whole Blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in KAT6A gene coding regions", "Pathogenic variants in KAT6A gene splice sites"] Parameters [] Preparation [] Indications ["Suspected autosomal dominant intellectual disability type 32", "Family history of KAT6A-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81261-6 ICD-10: F78.9 Clinical summary This diagnostic test evaluates the KAT6A gene for pathogenic variants associated with autosomal dominant intellectual disability type 32.
TEST-4288 KCNQ2 Genetic Test (Early Infantile Epileptic Encephalopathy Type 7) This test identifies pathogenic mutations in the KCNQ2 gene associated with early infantile epileptic encephalopathy type 7.	Peripheral Whole Blood or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNQ2 gene", "Point mutations", "Small insertions", "Small deletions"] Parameters [{"name": "Molecular Detection Rate", "reference_range": "99.9% (high-depth NGS coverage)"}] Preparation ["No specific fasting required", "Do not discontinue prescribed antiepileptic drugs without consulting your treating physician"] Indications ["Infants presenting with drug-resistant seizures", "Developmental delay", "Family history of early-onset epilepsy"] Measurement technique Confirm with laboratory Codes LOINC: 94231-0 ICD-10: G40.4 Clinical summary This test identifies pathogenic mutations in the KCNQ2 gene associated with early infantile epileptic encephalopathy type 7.
TEST-4143 MAPT Gene Testing for Frontotemporal Dementia (NGS) Test This test analyzes the MAPT gene for pathogenic mutations linked to frontotemporal lobar degeneration (FTLD-tau subtype).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MAPT gene coding region", "Pathogenic mutations", "Copy number variations"] Parameters [] Preparation [] Indications ["Suspected inherited frontotemporal dementia", "Risk stratification for dementia", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 92821-5 ICD-10: G31.09 Clinical summary This test analyzes the MAPT gene for pathogenic mutations linked to frontotemporal lobar degeneration (FTLD-tau subtype).
TEST-4077 MPZ Gene CMT2J Next‑Generation Sequencing (NGS) Genetic Test This genetic test identifies pathogenic variants in the MPZ gene, confirming a diagnosis of Charcot-Marie-Tooth disease type 2J (CMT2J).	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MPZ gene coding region variants", "Point mutations", "Small insertions/deletions", "Copy-number variants"] Parameters [] Preparation ["Attend a mandatory pre-test genetic counselling session", "Inform phlebotomist of all current medications", "No fasting required"] Indications ["Adults and children with suspected axonal hereditary neuropathy", "Positive family history or sporadic presentation consistent with CMT2J", "Clinical suspicion of CMT2"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G60.0 Clinical summary This genetic test identifies pathogenic variants in the MPZ gene, confirming a diagnosis of Charcot-Marie-Tooth disease type 2J (CMT2J).
TEST-4216 MPZ Gene DI‑CMTD Genetic Test This test detects mutations, including deep intronic and copy number variants, in the MPZ gene associated with Dominant Intermediate Charcot-Marie-Tooth Disease (DI-CMTD).	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the MPZ gene", "Copy number variations in the MPZ gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling is required", "No fasting is needed"] Indications ["Suspected diagnosis of DI-CMTD", "Family history of hereditary neuropathy", "Need for genetic subtyping of neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 81263-2 ICD-10: G60.0 Clinical summary This test detects mutations, including deep intronic and copy number variants, in the MPZ gene associated with Dominant Intermediate Charcot-Marie-Tooth Disease (DI-CMTD).
TEST-3855 MXRA5 Gene Autism Spectrum Genetic Test This test identifies pathogenic variants in the MXRA5 gene associated with autism spectrum disorder.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MXRA5 gene", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation ["No special preparation required", "Pre-test genetic counselling is mandatory"] Indications ["Clinical suspicion of a monogenic cause of ASD", "Complex ASD presentations", "Positive family history of neurogenetic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94219-6 ICD-10: F84.0 Clinical summary This test identifies pathogenic variants in the MXRA5 gene associated with autism spectrum disorder.
TEST-4985 NDST1 Gene Analysis (Intellectual Disability, Autosomal Recessive Type 46) Genetic Test This test identifies pathogenic variants in the NDST1 gene associated with autosomal recessive intellectual disability type 46.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card dried blood spot; extracted DNA accepted	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDST1 gene"] Parameters [] Preparation [] Indications ["Evaluation of unexplained developmental delay", "Evaluation of hypotonia", "Family history of neurogenetic disorders", "Diagnosis of intellectual disability type 46"] Measurement technique Confirm with laboratory Codes LOINC: 82326-0 ICD-10: F79, F78.A1 Clinical summary This test identifies pathogenic variants in the NDST1 gene associated with autosomal recessive intellectual disability type 46.
TEST-5671 NOTCH4 Gene Schizophrenia Genetic Test This test identifies pathogenic variants in the NOTCH4 gene associated with schizophrenia susceptibility.	Blood, Extracted DNA, or One-drop Blood on FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NOTCH4 gene"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Clinical history and pedigree chart mandatory"] Indications ["Assessment of genetic predisposition to schizophrenia", "Risk stratification in individuals with family history of schizophrenia"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: F20.9, Z13.858, Z13.7 Clinical summary This test identifies pathogenic variants in the NOTCH4 gene associated with schizophrenia susceptibility.

Category overview

Neurogenetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurogenetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurogenetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.